ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
18.40
+0.80 (4.55%)
At close: Jun 26, 2025, 4:00 PM
18.50
+0.10 (0.54%)
Pre-market: Jun 27, 2025, 7:00 AM EDT
ADMA Biologics Employees
ADMA Biologics had 685 employees as of December 31, 2024. The number of employees increased by 61 or 9.78% compared to the previous year.
Employees
685
Change (1Y)
61
Growth (1Y)
9.78%
Revenue / Employee
$670,629
Profits / Employee
$301,855
Market Cap
4.39B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ADMA News
- 12 days ago - ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade) - Seeking Alpha
- 7 weeks ago - ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss - Seeking Alpha
- 7 weeks ago - ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025 - GlobeNewsWire
- 2 months ago - ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process - GlobeNewsWire
- 2 months ago - ADMA Biologics Statement on Tariffs - GlobeNewsWire
- 3 months ago - ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential - Seeking Alpha